Mayne Pharma GroupMAYNF 43 Days Inventory is 120.49 as of Dec. 2025, which is 20% below its 10-year median of 150.84. GuruFocus rates MAYNF with a GF Score™ of 43/100 and a GF Value™ of $3.41 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 115 Medical Distribution companies, Mayne Pharma Group ranks worse than 83.48% on this metric.
The historical rank and industry rank for Mayne Pharma Group's Days Inventory or its related term are showing as below:
MAYNF'
s Days Inventory Range Over the Past 10 Years
Min: 103.27 Med: 150.84 Max: 349.34
Current: 127.26
During the past 13 years, Mayne Pharma Group's highest Days Inventory was 349.34. The lowest was 103.27. And the median was 150.84.
MAYNF's Days Inventory is ranked worse than 83.48% of 115
companies
in the Medical Distribution industry
Industry Median: 57.73
vs MAYNF: 127.26
Mayne Pharma Group's Days Inventory
declined
from Dec. 2024 (154.65) to Dec. 2025 (120.49).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Mayne Pharma Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.51.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mayne Pharma Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.23.
Mayne Pharma Group (OTCPK:MAYNF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Mayne Pharma Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mayne Pharma Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Mayne Pharma Group Days Inventory Related Terms
Mayne Pharma Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Mayne Pharma Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Mayne Pharma Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mayne Pharma Group Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Mayne Pharma Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Mayne Pharma Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mayne Pharma Group (MAYNF) has a Days Inventory of 120.49 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mayne Pharma Group and its competitors. This is 20% below median its historical median of 150.84. Over the past decade, Mayne Pharma Group's Days Inventory has ranged from 103.27 to 349.34. According to the industry distribution chart, Mayne Pharma Group ranks #96 out of 115 companies in the Medical Distribution industry, placing it in the top 83.5%.
Is Mayne Pharma Group's Days Inventory too high?
Mayne Pharma Group's current Days Inventory of 120.49 is 20% below median its 10-year median of 150.84. Over the past 10 years, this metric has ranged from a low of 103.27 to a high of 349.34. The Medical Distribution industry median Days Inventory is 57.73. Mayne Pharma Group's value of 120.49 is 108.7% above this industry median. Based on the distribution chart, Mayne Pharma Group ranks #96 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Mayne Pharma Group has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mayne Pharma Group's Days Inventory compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Mayne Pharma Group ranks #96 out of 115 companies for Days Inventory. This places Mayne Pharma Group in the lower half of its industry. The industry median Days Inventory is 57.73. Mayne Pharma Group's value of 120.49 is 108.7% above this benchmark. Historically, Mayne Pharma Group's own Days Inventory has ranged from 103.27 to 349.34 over the past decade. While the company's 10-year median is 150.84 vs. the industry median of 57.73, Mayne Pharma Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.73, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mayne Pharma Group's current Days Inventory of 120.49 is 108.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mayne Pharma Group and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mayne Pharma Group's current Days Inventory is 120.49, which is 20% below median its own 10-year median of 150.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayne Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.41, compared to a current price of $1.65 — trading 51.6% below its estimated fair value. The current Days Inventory is 120.49, which is 20% below median its 10-year median of 150.84 and 108.7% above the Medical Distribution industry median of 57.73. Mayne Pharma Group's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current Days Inventory is 120.49 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mayne Pharma Group (MAYNF) Overvalued in 2026?
Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued.
The current stock price of $1.65 is trading 51.6% below its estimated GF Value™ of $3.41.
GuruFocus considers Mayne Pharma Group to be Possible Value Trap.
Key valuation signals for MAYNF:
Days Inventory: 120.49 (20% below median its 10-year median of 150.84)
GF Value™: $3.41 vs. price of $1.65 (51.6% below fair value)
Industry Position: 108.7% above the Medical Distribution median (#96 of 115)
No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
43GF Score
Get the complete analysis for MAYNF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAYNF has been successfully added to your 
